riluzole has been researched along with Lassitude in 4 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fatigue is a common and disabling symptom of multiple sclerosis (MS) patients." | 1.43 | Longitudinal associations between brain structural changes and fatigue in early MS. ( Azevedo, C; Maghzi, AH; Nourbakhsh, B; Nunan-Saah, J; Pelletier, D; Spain, R; Waubant, E, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beswick, E | 1 |
| Forbes, D | 1 |
| Hassan, Z | 1 |
| Wong, C | 1 |
| Newton, J | 1 |
| Carson, A | 1 |
| Abrahams, S | 1 |
| Chandran, S | 1 |
| Pal, S | 1 |
| Nourbakhsh, B | 3 |
| Revirajan, N | 1 |
| Waubant, E | 3 |
| Azevedo, C | 1 |
| Nunan-Saah, J | 1 |
| Maghzi, AH | 1 |
| Spain, R | 1 |
| Pelletier, D | 1 |
| Julian, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Using Patient-Reported Outcomes To Improve the Care of People With Multiple Sclerosis: A Randomized Trial[NCT04979546] | 356 participants (Anticipated) | Interventional | 2021-11-04 | Recruiting | |||
| MS Wellness Navigator: The Effect of Nurse Practitioner (NP-led) Care on Mood, Anxiety and Health Related Quality of Life in People With Multiple Sclerosis - A Randomized Trial[NCT04388592] | 248 participants (Actual) | Interventional | 2017-04-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for riluzole and Lassitude
| Article | Year |
|---|---|
A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Fatigue; Humans; Pain; Riluzole; Symptom Assessment | 2022 |
2 trials available for riluzole and Lassitude
| Article | Year |
|---|---|
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Topics: Adult; Double-Blind Method; Excitatory Amino Acid Antagonists; Fatigue; Female; Humans; Male; Middle | 2015 |
Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study.
Topics: Adult; Cross-Sectional Studies; Depression; Fatigue; Female; Humans; Longitudinal Studies; Male; Mid | 2016 |
Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study.
Topics: Adult; Cross-Sectional Studies; Depression; Fatigue; Female; Humans; Longitudinal Studies; Male; Mid | 2016 |
Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study.
Topics: Adult; Cross-Sectional Studies; Depression; Fatigue; Female; Humans; Longitudinal Studies; Male; Mid | 2016 |
Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study.
Topics: Adult; Cross-Sectional Studies; Depression; Fatigue; Female; Humans; Longitudinal Studies; Male; Mid | 2016 |
1 other study available for riluzole and Lassitude
| Article | Year |
|---|---|
Longitudinal associations between brain structural changes and fatigue in early MS.
Topics: Adult; Atrophy; Brain; Fatigue; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Ma | 2016 |